| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TRIO and F-actin binding protein | 0.743 | 0.269 | 2.0E-28 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
pejvakin | 0.769 | 0.115 | 3.7E-08 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
POU class 3 homeobox 4 | 0.633 | 0.654 | 0.57 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 1995 | 2009 | ||||||||
|
immunoglobulin like domain containing receptor 1 | 0.729 | 0.346 | 2.6E-12 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
MARVEL domain containing 2 | 0.705 | 0.462 | 1.3E-12 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
SIX homeobox 1 | 0.496 | 0.692 | 0.65 |
|
phenotype | 0.420 | strong | 0.667 | 1 | 0 | 1998 | 2011 | ||||||||
|
forkhead box C1 | 0.483 | 0.846 | 0.95 |
|
phenotype | 0.410 | strong | 0.500 | 1 | 0 | 2004 | 2013 | ||||||||
|
adhesion G protein-coupled receptor V1 | 0.572 | 0.731 | 3.2E-39 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
chromodomain helicase DNA binding protein 7 | 0.441 | 0.846 | 1.00 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 2014 | 2018 | ||||||||
|
myosin IIIA | 0.780 | 0.269 | 1.8E-45 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 2011 | 2016 | ||||||||
|
collagen type IV alpha 5 chain | 0.553 | 0.654 | 1.00 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 1995 | 1997 | ||||||||
|
glutaredoxin and cysteine rich domain containing 1 | 0.861 | 0.115 | 3.9E-11 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
phenotype | 0.410 | None | 1.000 | 0 | 0 | 2015 | 2015 | ||||||||
|
transmembrane inner ear | 0.890 | 0.115 | 7.7E-05 |
|
phenotype | 0.410 | strong | < 0.001 | 0 | 0 | 2006 | 2006 | ||||||||
|
spalt like transcription factor 4 | 0.489 | 0.769 | 1.00 |
|
phenotype | 0.410 | strong | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
polyribonucleotide nucleotidyltransferase 1 | 0.653 | 0.462 | 4.0E-04 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1996 | 2006 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1992 | 2006 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
cochlin | 0.659 | 0.385 | 1.2E-07 |
|
phenotype | 0.400 | strong | 0.909 | 1 | 0 | 1999 | 2019 | ||||||||
|
claudin 14 | 0.705 | 0.462 | 1.1E-04 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
GIPC PDZ domain containing family member 3 | 0.780 | 0.231 | 9.3E-03 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
taperin | 0.839 | 0.115 | 7.2E-03 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
EYA transcriptional coactivator and phosphatase 1 | 0.531 | 0.731 | 0.95 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 1998 | 1998 |